Dr. Lal Path Labs Ltd. has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has submitted to the exchanges a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited, and covers the quarter ended June 30, 2025. The RTA confirmed that no dematerialisation requests were received during the quarter. The filing also notes that the company does not have any physical shares, meaning all its shares are already held in demat form. This is a routine quarterly regulatory compliance submission.
This is a routine procedural filing with no material impact on the stock price or shareholders. It simply confirms that all Dr. Lal Path Labs shares are held in dematerialised form and the company is in good regulatory standing with depositories.